Trial Profile
Relative Bioavailability of Different Salt Forms and Formulations of Single Doses Either 50 or 200 mg BI 671800 in the Fasted or Fed State. An Open-label, Randomised, Phase I Study With a 3-period Crossover Followed by Two Treatment Periods in Fixed Sequence in Healthy Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2014
Price :
$35
*
At a glance
- Drugs BI 671800 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 23 Aug 2014 New trial record